KATHRYN HELSON: Open Payments
NPI 1134872542 · GALLATIN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$493 in 36 payments from 9 companies in 2025. Trend: 2023 $1,604 · 2024 $1,769 · 2025 $493
Food & beverage: $493
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $250 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| Novo Nordisk Inc | 2 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Lundbeck LLC | 1 | $30 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $19 |
| Exact Sciences Corporation | 1 | $16 |
Products named: VRAYLAR, UBRELVY, REXULTI, BREZTRI, Wegovy, QULIPTA, XIFAXAN, CAPLYTA.
Industry payments across TN — which companies pay providers there.
